The TLR9 agonist (GNKG168) induces a unique immune activation pattern in vivo in children with minimal residual disease positive acute leukemia: Results of the TACL T2009-008 phase I study

2019 ◽  
Vol 36 (8) ◽  
pp. 468-481
Author(s):  
Rebecca Ronsley ◽  
Amina Kariminia ◽  
Bernard Ng ◽  
Sara Mostafavi ◽  
Gregor Reid ◽  
...  
Keyword(s):  
Acute Leukemia ◽  
Phase I ◽  
Minimal Residual Disease ◽  
Immune Activation ◽  
Phase I Study ◽  
Residual Disease ◽  
Activation Pattern ◽  
Tlr9 Agonist ◽  
Minimal Residual

scholarly journals Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease

Cytometry ◽  
1992 ◽  
Vol 13 (8) ◽  
pp. 893-901 ◽  
Author(s):  
Johannes Drach ◽  
Doris Drach ◽  
Herta Glassl ◽  
Claus Gattringer ◽  
Heinz Huber
Keyword(s):  
Acute Leukemia ◽  
Minimal Residual Disease ◽  
Residual Disease ◽  
Antigen Expression ◽  
Flow Cytometric ◽  
Minimal Residual
Sign in / Sign up

Export Citation Format

Share Document